Author | Shyam Patel, PharmD

Articles

New Drug Review: Spravato

June 13, 2019

Both responder and remitter patients experienced a statistically significant longer time to relapse with esketamine compared to the placebo

What Pharmacists Need to Know About Lofexidine

October 01, 2018

FDA approves lofexidine for opioid withdrawal symptoms.